コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 itivity of peripheral nerves to light touch (tactile allodynia).
2 s tactile stimulation elicits pain behavior (tactile allodynia).
3 ontribute to peripheral inflammation-induced tactile allodynia.
4 5-LOX (Zileuton) dose-dependently attenuated tactile allodynia.
5 carrageenan-induced thermal hyperalgesia and tactile allodynia.
6 ateral spinal dorsal horn of rats displaying tactile allodynia.
7 ulation do not display a learning deficit or tactile allodynia.
8 these afferents contributes to the resulting tactile allodynia.
9 and intraepidermal nerve fiber loss but not tactile allodynia.
10 2delta-1 subunit and reversed injury-induced tactile allodynia.
11 hermore, to the behavioural manifestation of tactile allodynia.
12 2delta-1 subunit upregulation and diminished tactile allodynia.
13 rog/day) for 5 days significantly attenuated tactile allodynia.
14 onset and diminished in rats recovering from tactile allodynia.
15 rn, has been implicated in the expression of tactile allodynia.
16 nerve-ligated rats and its correlation with tactile allodynia, a neuropathic pain state defined as r
17 normal chow after 16 weeks on HFD alleviated tactile allodynia and essentially corrected thermal hypo
20 ation of dynorphin A(1-17) antiserum blocked tactile allodynia and reversed thermal hyperalgesia to a
21 ed rats, i.th. morphine was inactive against tactile allodynia and showed diminished in potency again
22 s delivering morphine displayed time-related tactile allodynia and thermal hyperalgesia (i.e., opioid
23 k-out mice developed significantly increased tactile allodynia and thermal hyperalgesia in both the e
24 sed with DAMGO, but not saline, demonstrated tactile allodynia and thermal hyperalgesia of the hindpa
27 locity (SNCV) deficits, thermal hypoalgesia, tactile allodynia, and a remarkable ( approximately 78%)
28 motor and sensory nerve conduction deficits, tactile allodynia, and thermal hypoalgesia in the absenc
29 .th.) morphine is ineffective in suppressing tactile allodynia at fully antinociceptive doses in thes
30 d and dorsal root ganglia (DRG) of rats with tactile allodynia because of either tight ligation of th
31 XA(3), or HXB(3) evoked profound, persistent tactile allodynia, but 12(S)-HpETE and HXA(3) produced r
33 siRNA normalized mechanical hyperalgesia and tactile allodynia caused by SNL but had no significant e
36 hic pain model in which gabapentin-sensitive tactile allodynia develops after tight ligation of the l
38 Systemic A-134974 dose-dependently reduced tactile allodynia (ED(50)=5 micromol/kg, i.p.) for up to
40 stration of the TAT-4BB reversed M3G-induced tactile allodynia in a dose-dependent manner but did not
41 t tool molecule 20 (AM-1488), which reversed tactile allodynia in a mouse spared-nerve injury (SNI) m
42 n a hyperalgesia at the site of injury and a tactile allodynia in areas adjacent to the injury site.
45 lazine completely blocked the development of tactile allodynia in diabetic rats, whereas relatively m
47 algesic tolerance, thermal hyperalgesia, and tactile allodynia in response to chronic intrathecal mor
48 hese compounds, 23 dose dependently reversed tactile allodynia in the Chung model of neuropathic pain
49 f formalin-induced flinching, and attenuated tactile allodynia in the spinal nerve ligation model of
50 mically and spinally can effectively relieve tactile allodynia in this animal model of postherpetic n
52 ct of systemic and intrathecal gabapentin on tactile allodynia induced by resiniferotoxin in rats.
54 nerve crush resulted in a patchy but marked tactile allodynia manifesting first at 3 weeks and persi
55 viated diabetes-induced thermal hypoalgesia, tactile allodynia, motor and sensory nerve conduction ve
56 cation of icilin (0.1nM to 1microM) affected tactile allodynia or thermal hyperalgesia after SNL, but
57 syndrome) or by mechanical hyperalgesia and tactile allodynia (pain in response to nonpainful stimul
60 such as the loss of tactile sensitivity and tactile allodynia seen in patients who have diabetes, in
61 as more potent (ED(50)=10 nmol) in relieving tactile allodynia than delivering the compound by intrac
62 ited time-dependent and reversible cutaneous tactile allodynia that was maintained throughout and tra
63 novel AK inhibitor A-134974 potently reduces tactile allodynia through interactions with spinal sites
64 ats with streptozotocin-induced diabetes and tactile allodynia, using in situ hybridization and immun
68 ssess the role of NO in nerve injury-induced tactile allodynia, we examined neuronal NO synthase (nNO
69 orn neurons may result in the development of tactile allodynia, where non-painful stimuli gain the ca
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。